Product Information

ALLOPURINOL 300 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0546 per EA under NDC 59651028601. Its NADAC has been published 51 times since Sep 3, 2025.

FDA first approved this application on Apr 14, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ALLOPURINOL 300 MG TABLET

Allopurinol
$0.0546per EA

Strength

300 mg/1

NDC

59651028601

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ALLOPURINOL

Approval Type

Generic (ANDA)

FDA Application

ANDA215091

FDA Approved

4/14/2025

TE Code

AB

On Market Since

4/14/2025

Pharmacological Classes

Xanthine Oxidase Inhibitor
Xanthine Oxidase Inhibitors

Price Statistics

The NADAC for ALLOPURINOL 300 MG TABLET has been published 51 times since Sep 3, 2025, and over the history we have for it it has declined 18.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0546 per EA
All-time high$0.0674 (Sep 10, 2025)
All-time low$0.0546 (Aug 19, 2026)
52-week high$0.0674
52-week low$0.0546
Median price$0.0589
Average price$0.0601
Largest weekly change-5.0% (Feb 18, 2026)
Weeks tracked51
Tracking sinceSep 3, 2025

Price History

1W

-2.2%

1M

-2.2%

3M

-3.0%

6M

-7.2%

1Y

N/A

3Y

N/A

5Y

N/A

All

-18.9%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ALLOPURINOL 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ALLOPURINOL 300 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0546 per EA (NDC 59651028601), effective Aug 19, 2026.

How has the price of ALLOPURINOL 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for ALLOPURINOL 300 MG TABLET has declined 18.9%. It has been tracked across 51 weekly CMS publications since Sep 3, 2025.

What are the highest and lowest recorded NADAC prices for ALLOPURINOL 300 MG TABLET?

Since Sep 3, 2025, the NADAC for ALLOPURINOL 300 MG TABLET has ranged from a low of $0.0546 (Aug 19, 2026) to a high of $0.0674 (Sep 10, 2025), with a median of $0.0589 per EA.

Are there cheaper alternatives to ALLOPURINOL 300 MG TABLET?

11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ALLOPURINOL 300 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ALLOPURINOL 300 MG TABLET?

ALLOPURINOL 300 MG TABLET (NDC 59651028601) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.